Reported 1 day ago
Eli Lilly and Company (NYSE: LLY) is highlighted as one of billionaire Ken Fisher's top healthcare investments, boasting an impressive upside potential of 24.73%. The healthcare sector is experiencing significant transformations, driven by technological advancements like AI and pressures from geopolitical developments and changing demographics. Eli Lilly's innovative approaches in diabetes and cancer treatments, alongside recent strong sales performance, position it favorably despite challenges facing the industry. With critical trials and findings expected in 2025, Eli Lilly remains a compelling choice for investors.
Source: YAHOO